NCT00093665 Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer Status UNKNOWN Phase PHASE2
NCT00090337 Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00089297 Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00084435 S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer Status WITHDRAWN Phase PHASE2
NCT00084318 Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck Status COMPLETED Phase PHASE2
NCT00083057 Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE1
NCT00081029 Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia Status UNKNOWN Phase PHASE3
NCT00080028 Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer Status TERMINATED Phase PHASE1
NCT00079079 Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor Status COMPLETED Phase PHASE2
NCT00079053 Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE1
NCT00077103 Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00077051 Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat) Status COMPLETED Phase PHASE1
NCT00076310 OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer Status COMPLETED Phase PHASE2
NCT00068237 Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00066651 Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00064298 Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00062387 Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT00062348 Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases Status COMPLETED Phase PHASE1
NCT00061906 Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer Status COMPLETED Phase PHASE2
NCT00060242 Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer Status COMPLETED Phase PHASE2